A Kanata manufacturer says it plans to invest $1.5-million in new technology to ramp up production of materials used in laboratory tests for COVID-19 and other infectious diseases.
Evik Diagnostic Innovations recently received a $500,000 funding boost from the provincial government. The company says it will put the cash from the Ontario Together Fund toward its plans to increase production of assay reagents, freeze-dried pellets used in diagnostic equipment that detects and analyzes symptoms of diseases such as COVID-19, HIV and anthrax.
The pellets also allow medical device manufacturers to store and ship their devices to remote locations at the proper temperature.
OBJ360 (Sponsored)

Experience full service strategic property management with Sleepwell Property Management
Since 2005, Sleepwell Property Management has been at the forefront of residential and commercial property management in Ottawa and the surrounding regions. What began as a local venture has grown

Growing the heart of Orléans – one business at a time
The Heart of Orléans Business Improvement Area (BIA) is a local board of Ottawa City Council, guided by a volunteer board of management and established in 2006. The BIA represents
The company says demand for reagent pellets has surged during the pandemic. It plans to build an automated assembly line that will speed up the production of reagent pellets and will also purchase robotic arms, set up robotic stations and build an artificial intelligence-driven assembly station.
“To be competitive and resilient in times of pandemic, companies like us must find ways to be innovative and collaborative,” Evik Diagnostic CEO Vladimir Evtodienko said in a statement.